SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients
Clinical trial NCT05313074 · COMPLETED
Trial details
- NCT number
- NCT05313074
- Sponsor
- National Cancer Institute, Thailand
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2022-02-25
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.